ASPIRA PATHLAB & DIAGNOSTICS
|
The Current P/S Ratio of ASPIRA PATHLAB & DIAGNOSTICS is 4.87.
| Share Price | ₹106.9 | Aug 07,2026 |
| Market Cap | ₹110.1 Cr | |
| Sales-TTM | ₹22.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.87x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ASPIRA PATHLAB & DIAGNOSTICS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹110.1 Cr] as on Aug 07,2026
(/) Sales [ ₹22.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.87x ]
Thus, for ASPIRA PATHLAB & DIAGNOSTICS , the investors are currently willing to pay '4.87 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ASPIRA PATHLAB & DIAGNOSTICS !
The chart below summarizes the trend in P/S Ratio of ASPIRA PATHLAB & DIAGNOSTICS over the last five years.
Historical PS (Price/Sales) ratio chart of ASPIRA PATHLAB & DIAGNOSTICS
PS Ratio Performance Analysis for ASPIRA PATHLAB & DIAGNOSTICS
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio for fiscal years ending Mar2025 to Mar2024 averaged 3.21x.
- ASPIRA PATHLAB & DIAGNOSTICS 's operated at median p/e ratio of 3.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio peaked in Mar2025 at 3.99x.
- ASPIRA PATHLAB & DIAGNOSTICS 's p/e ratio hit its five-year low in Mar2024 of 2.42x.
How does ASPIRA PATHLAB & DIAGNOSTICS 's P/S Ratio benchmark against top 10 peers in Hospital & Healthcare Services Industry?
| Peer Comparison (Hospital & Healthcare Services Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ASPIRA PATHLAB & DIAGNOSTICS | 22.6 | 4.87 | 110.1 |
| APOLLO HOSPITALS ENTERPRISE LTD | 25,228.5 | 5.12 | 129,126.0 |
| MAX HEALTHCARE INSTITUTE LTD | 8,373.5 | 12.47 | 104,432.0 |
| FORTIS HEALTHCARE LTD | 9,506.2 | 7.62 | 72,476.0 |
| ASTER DM HEALTHCARE LTD | 4,876.0 | 15.56 | 75,861.6 |
| NARAYANA HRUDAYALAYA LTD | 9,072.4 | 4.24 | 38,501.6 |
| GLOBAL HEALTH LTD | 4,683.4 | 8.35 | 39,120.8 |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 4,212.5 | 8.09 | 34,062.5 |
| DR LAL PATHLABS LTD | 2,890.8 | 11.21 | 32,417.5 |
| DR AGARWALS HEALTH CARE LTD | 2,206.7 | 7.85 | 17,322.3 |
| RAINBOW CHILDRENS MEDICARE LTD | 1,820.1 | 8.68 | 15,800.2 |
Hospital & Healthcare Services Industry Benchmark (Top 10) PS Analysis vs ASPIRA PATHLAB & DIAGNOSTICS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 4.24x |
| Max industry PS | 15.56x |
| Median industry PS | 8.09x |
| Average industry PS | 8.55x |
You may also like the below Video Courses